Results 11 to 20 of about 11,268,090 (297)

Change in albuminuria and subsequent risk of end-stage kidney disease: An individual participant-level consortium meta-analysis of observational studies [PDF]

The Lancet Diabetes and Endocrinology, 2019
Background: There is strong biologic plausibility to support change in albuminuria as a surrogate endpoint for progression of chronic kidney disease (CKD), but empirical evidence to supports its validity in epidemiologic studies is lacking.
J. Coresh, H. Heerspink, Y. Sang, K. Matsushita, J. Arnlov, B. Astor, C. Black, N. Brunskill, J. Carrero, H. Feldman, C. Fox, L. Inker, A. Ishani, S. Ito, S. Jassal, T. Konta, K. Polkinghorne, S. Romundstad, M. Solbu, Nikita Stempniewicz, B. Stengel, M. Tonelli, M. Umesawa, S. Waikar, C. Wen, J. Wetzels, M. Woodward, M. Grams, C. Kovesdy, A. Levey, R. Gansevoort, Lawrence J. Appel, Tom Greene, Teresa K. Chen, John P. Chalmers, H. Arima, V. Perkovic, Adeera Levin, O. Djurdjev, M. Tang, Joseph V. Nally, S. Navaneethan, J. Schold, M. Weldegiorgis, W. Herrington, Margaret Smith, C. Hsu, Shih-Jen Hwang, Alex R. Chang, H. Kirchner, J. Green, Kevin Ho, A. Marks, Gordon Prescott, Laura E. Clark, N. Fluck, V. Shalev, Gabriel Chodick, P. Blankestijn, A. V. van Zuilen, J. van den Brand, M. Sarnak, E. Bottinger, Girish N. Nadkarni, Stephen G. Ellis, Rajiv Nadukuru, Marie Metzger, M. Flamant, P. Houillier, J. Haymann, Marc Froissart, T. Kenealy, Raina C. Elley, J. Collins, P. Drury, J. Cuddeback, E. Ciemins, Rich Stempniewicz, R. Nelson, W. Knowler, S. J. Bakker, R. Major, J. Medcalf, David Shepherd, E. Barrett-Connor, J. Bergstrom, J. H., M. Molnar, Keiichi Sumida, D. de Zeeuw, B. Brenner, A. Qureshi, C. Elinder, B. Runesson, Marie Evans, Mårten Segelmark, M. Stendahl, S. Schön, D. Naimark, N. Tangri, M. Sud, A. Hirayama, K. Ichikawa, H. Bilo, G. Landman, K. V. van Hateren, Nanne Kleefstra, Stein I. Hallan, S. Ballew, Jing-Sha Chen, Lucia Kwak, A. Surapaneni, Hans-Henrik Parving, R. Rodby, R. Rohde, Julia B. Lewis, E. Lewis, Ronald D. Perrone, K. Abebe, Fan F. Hou, D. Xie, L. Hunsicker, Enyu Imai, F. Kobayashi, Hirofumi Makino, Giuseppe Remuzzi, P. Ruggenenti, K.-U. Eckardt, H. Gudmundsdóttir, R. Mačiulaitis, Tom Manley, Kimberly Smith, N. Stockbridge, A. Thompson, Thorsten Vetter, K. Willis, Lu-Xia Zhang   +136 more
semanticscholar   +3 more sources

Vitamin D and endothelial function in chronic kidney disease [PDF]

, 2014
PhDVitamin D deficiency in patients with chronic kidney disease, measured by reduced serum concentrations of 25 hydroxy vitamin D, is highly prevalent and associated with both endothelial dysfunction and an increased risk of cardiovascular disease ...
Dreyer, Gavin
core   +4 more sources

The spatial analysis of diagnosed Chronic Kidney Disease in Nigeria: A case study of Edo State [PDF]

, 2012
The thesis explores the severity of diagnosed chronic kidney disease (CKD) with particular reference to its impact in Edo state, Nigeria. There has been a scarcity of studies on the prevalence and spatial patterns of CKD in developing countries even ...
Oviasu, Osaretin
core   +6 more sources

Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?

Biomedicines, 2023
The gut microbiota (GM) plays a vital role in human health, with increasing evidence linking its imbalance to chronic kidney disease and end-stage kidney disease.
Alexandru Cosmin Pantazi, M. A. Kassim, Wassan Nori, Liliana Ana Tuta, Cristina Maria Mihai, Tatiana Chisnoiu, Adriana Luminita Balasa, L. Mihai, Ancuța Lupu, Corina Elena Frecus, V. Lupu, S. Chirilă, A. Bădescu, Laurentiu-Tony Hangan, Simona Claudia Cambrea   +14 more
semanticscholar   +1 more source

Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality

JAMA Network Open, 2022
Key Points Question Are differences between estimated glomerular filtration rate by cystatin C (eGFRcys) vs creatinine (eGFRcr) associated with the risk of end-stage kidney disease (ESKD) and mortality among individuals with chronic kidney disease (CKD)?
Debbie C. Chen, Michael G. Shlipak, Rebecca Scherzer, Scott R. Bauer, O. Potok, D. Rifkin, J. H., Anthony N. Muiru, Chi-Yuan Hsu, M. Estrella   +9 more
semanticscholar   +1 more source

Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4

BMC Nephrology, 2023
Introduction End-stage kidney disease (ESKD) is associated with increased morbidity and mortality. Identifying patients with stage 4 CKD (CKD4) at risk of rapid progression to ESKD remains challenging.
Kullaya Takkavatakarn, Wonsuk Oh, Ella Cheng, Girish N Nadkarni, Lili Chan   +4 more
doaj   +1 more source

Reported Cases of End-Stage Kidney Disease — United States, 2000–2019

MMWR. Morbidity and mortality weekly report, 2022
End-stage kidney disease (ESKD) (kidney failure requiring dialysis or transplantation) is a costly and disabling condition that often results in premature death (1).
N. R. Burrows, Alain K. Koyama, Meda E. Pavkov   +2 more
semanticscholar   +1 more source

Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
Background Heart failure with reduced ejection fraction (HFrEF) is a chronic disease with substantial mortality. Management of HFrEF has seen significant breakthrough after the launch of neprilysin inhibitor.
Chih-Yuan Niu, Shang-Feng Yang, Shuo-Ming Ou, Cheng-Hsueh Wu, Po-Hsun Huang, Chung-Lieh Hung, Chih-Ching Lin, Szu-Yuan Li   +7 more
semanticscholar   +1 more source

Wearable and implantable artificial kidney devices for end-stage kidney disease treatment-Current status and review.

Artificial Organs, 2022
BACKGROUND Chronic kidney disease (CKD) is a major cause of early death worldwide. By 2030, 14.5 million people will have end-stage kidney disease (ESKD, or CKD stage 5), yet only 5.4 million will receive kidney replacement therapy (KRT) due to economic,
T. Groth, B. Stegmayr, S. Ash, Janna Kuchinka, F. Wieringa, W. Fissell, Shuvo Roy   +6 more
semanticscholar   +1 more source

Diffuse calcification of a nonfunctioning kidney allograft

Clinical Case Reports, 2021
Diffuse calcification of nonfunctioning kidney graft may rarely occur in clinical practice, and it is generally benign and does not require transplant removal in most cases.
Gabriel Ștefan, Simona Cinca, Adrian Zugravu, Simona Stancu   +3 more
doaj   +1 more source